icone plus
Contact Abonnez-vous aux actualités
Reason for request
Re-assessment of the Actual Benefit
Clinical Benefit
Insufficient
The actual benefit of the proprietary medicinal product ROHYPNOL is insufficient in the treatment of "severe sleep disorders in the following cases: occasional insomnia, transient insomnia".
Therapeutic use
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
zWXbvMUMSwzYbNps
Listen
